StockData
Accustem Sciences Inc. logo

Accustem Sciences Inc. (ACUT) stock

ACUTOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.15+0.00 (0.00%)

Close on Oct 16, 2026Market cap $2.37MP/E –Yield –

Accustem Sciences enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Accustem Sciences's enterprise value was $2.36M on Oct 16, 2026, against $19.42M a year earlier. Over the last 5 years it ranged from $2.16M to $30.67M, with a median of $6.65M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 16, 2026$2.36M-82.0%
2025Dec 31, 2025$13.06M+158.8%
2024Dec 31, 2024$5.05M-28.2%
2023Dec 29, 2023$7.03M-49.7%
2022Dec 30, 2022$13.99M–

More Accustem Sciences figures

See a number that looks wrong?